{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:47:21Z","timestamp":1795006041121,"version":"4.9.1"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/R012490\/1"],"award-info":[{"award-number":["BB\/R012490\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BBS\/E\/F\/000PR10356"],"award-info":[{"award-number":["BBS\/E\/F\/000PR10356"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["SEG 9093"],"award-info":[{"award-number":["SEG 9093"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["EMBO ALTF 1030-2022"],"award-info":[{"award-number":["EMBO ALTF 1030-2022"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["395357507 \u2013 SFB 1371"],"award-info":[{"award-number":["395357507 \u2013 SFB 1371"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012116","name":"European Bioinformatics Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is strong interest in using the gut microbiome for Parkinson\u2019s disease (PD) diagnosis and treatment. However, a consensus on PD-associated microbiome features and a multi-study assessment of their diagnostic value is lacking. Here, we present a machine learning meta-analysis of PD microbiome studies of unprecedented scale (4489 samples). Within most studies, microbiome-based machine learning models accurately classify PD patients (average AUC 71.9%). However, these models are study-specific and do not generalise well across other studies (average AUC 61%). Training models on multiple datasets improves their generalizability (average LOSO AUC 68%) and disease specificity as assessed against microbiomes from other neurodegenerative diseases. Moreover, meta-analysis of shotgun metagenomes delineates PD-associated microbial pathways potentially contributing to gut health deterioration and favouring the translocation of pathogenic molecules along the gut-brain axis. Strikingly, microbial pathways for solvent and pesticide biotransformation are enriched in PD. These results align with epidemiological evidence that exposure to these molecules increases PD risk and raise the question of whether gut microbes modulate their toxicity. Here, we offer the most comprehensive overview to date about the PD gut microbiome and provide future reference for its diagnostic and functional potential.<\/jats:p>","DOI":"10.1038\/s41467-025-56829-3","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T06:35:05Z","timestamp":1746599705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Machine learning-based meta-analysis reveals gut microbiome alterations associated with Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7600-1953","authenticated-orcid":false,"given":"Stefano","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-3562","authenticated-orcid":false,"given":"Jakob","family":"Wirbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-481X","authenticated-orcid":false,"given":"Rebecca","family":"Ansorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1157-1354","authenticated-orcid":false,"given":"Christian","family":"Schudoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinten Raymond","family":"Ducarmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2968-7558","authenticated-orcid":false,"given":"Arjan","family":"Narbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-0079","authenticated-orcid":false,"given":"Georg","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"56829_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R. et al. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 939\u2013953 (2018).","journal-title":"Lancet Neurol."},{"key":"56829_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","volume":"172","author":"A Elbaz","year":"2016","unstructured":"Elbaz, A., Carcaillon, L., Kab, S. & Moisan, F. Epidemiology of Parkinson\u2019s disease. Rev. Neurol. 172, 14\u201326 (2016).","journal-title":"Rev. Neurol."},{"key":"56829_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"56829_CR4","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"56829_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W. & Przedborski, S. Parkinson\u2019s disease: Mechanisms and models. Neuron 39, 889\u2013909 (2003).","journal-title":"Neuron"},{"key":"56829_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","volume":"71","author":"MA Thenganatt","year":"2014","unstructured":"Thenganatt, M. A. & Jankovic, J. Parkinson disease subtypes. JAMA Neurol. 71, 499 (2014).","journal-title":"JAMA Neurol."},{"key":"56829_CR7","doi-asserted-by":"crossref","unstructured":"Konings, B. et al. Gastrointestinal syndromes preceding a diagnosis of Parkinson\u2019s disease: testing Braak\u2019s hypothesis using a nationwide database for comparison with Alzheimer\u2019s disease and cerebrovascular diseases. Gut 72, 2103\u20132111 (2023).","DOI":"10.1136\/gutjnl-2023-329685"},{"key":"56829_CR8","first-page":"S323","volume":"9","author":"SCD Van IJzendoorn","year":"2019","unstructured":"Van IJzendoorn, S. C. D. & Derkinderen, P. The intestinal barrier in Parkinson\u2019s disease: Current state of knowledge. J. Park. Dis. 9, S323\u2013S329 (2019).","journal-title":"J. Park. Dis."},{"key":"56829_CR9","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica, R. et al. Medical records documentation of constipation preceding Parkinson disease: A case-control study. Neurology 73, 1752\u20131758 (2009).","journal-title":"Neurology"},{"key":"56829_CR10","first-page":"408","volume":"70","author":"H-S Lee","year":"2020","unstructured":"Lee, H.-S., Lobbestael, E., Vermeire, S., Sabino, J. & Cleynen, I. Inflammatory bowel disease and Parkinson\u2019s disease: common pathophysiological links. Gut 70, 408\u2013417 (2020).","journal-title":"Gut"},{"key":"56829_CR11","doi-asserted-by":"publisher","first-page":"e12962","DOI":"10.1111\/nan.12962","volume":"50","author":"AM Espinosa\u2010Oliva","year":"2024","unstructured":"Espinosa\u2010Oliva, A. M. et al. Inflammatory bowel disease induces pathological \u03b1\u2010synuclein aggregation in the human gut and brain. Neuropathol. Appl. Neurobiol. 50, e12962 (2024).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"56829_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. Npj Park. Dis. 7, 27 (2021).","journal-title":"Npj Park. Dis."},{"key":"56829_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel, J. et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 25, 679\u2013689 (2019).","journal-title":"Nat. Med."},{"key":"56829_CR14","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki, H. et al. Meta-analysis of Gut Dysbiosis in Parkinson\u2019s disease. Mov. Disord. 35, 1626\u20131635 (2020).","journal-title":"Mov. Disord."},{"key":"56829_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen, Z. D. et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat. Commun. 13, 6958 (2022).","journal-title":"Nat. Commun."},{"key":"56829_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.29300","volume":"38","author":"JC Boktor","year":"2023","unstructured":"Boktor, J. C. et al. Integrated Multi\u2010Cohort Analysis of the Parkinson\u2019s Disease Gut Metagenome. Mov. Disord. 38, 399\u2013409 (2023).","journal-title":"Mov. Disord."},{"key":"56829_CR17","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"Y Qian","year":"2020","unstructured":"Qian, Y. et al. Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain 143, 2474\u20132489 (2020).","journal-title":"Brain"},{"key":"56829_CR18","doi-asserted-by":"publisher","unstructured":"Bedarf, J. R. et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med. 9, https:\/\/doi.org\/10.1186\/s13073-017-0428-y (2017).","DOI":"10.1186\/s13073-017-0428-y"},{"key":"56829_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-021-00272-w","volume":"8","author":"S Jo","year":"2022","unstructured":"Jo, S. et al. Oral and gut dysbiosis leads to functional alterations in Parkinson\u2019s disease. Npj Park. Dis. 8, 1\u201312 (2022).","journal-title":"Npj Park. Dis."},{"key":"56829_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/brainsci10040242","volume":"10","author":"D Pietrucci","year":"2020","unstructured":"Pietrucci, D. et al. Can Gut microbiota be a good predictor for Parkinson\u2019s disease? A machine learning approach. Brain Sci. 10, 242 (2020).","journal-title":"Brain Sci."},{"key":"56829_CR21","doi-asserted-by":"publisher","first-page":"881872","DOI":"10.3389\/fnagi.2022.881872","volume":"14","author":"M Lubomski","year":"2022","unstructured":"Lubomski, M. et al. Nutritional intake and gut microbiome composition predict Parkinson\u2019s disease. Front. Aging Neurosci. 14, 881872 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"56829_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-022-00367-z","volume":"8","author":"S Nie","year":"2022","unstructured":"Nie, S., Wang, J., Deng, Y., Ye, Z. & Ge, Y. Inflammatory microbes and genes as potential biomarkers of Parkinson\u2019s disease. Npj Biofilms Microbiomes 8, 1\u201310 (2022).","journal-title":"Npj Biofilms Microbiomes"},{"key":"56829_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02306-1","volume":"22","author":"J Wirbel","year":"2021","unstructured":"Wirbel, J. et al. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol. 22, 93 (2021).","journal-title":"Genome Biol."},{"key":"56829_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.parkreldis.2020.10.034","volume":"81","author":"F Zhang","year":"2020","unstructured":"Zhang, F. et al. Altered gut microbiota in Parkinson\u2019s disease patients\/healthy spouses and its association with clinical features. Parkinsonism Relat. Disord. 81, 84\u201388 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"56829_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan, A. H. et al. Gut microbial ecosystem in Parkinson disease: New clinicobiological insights from multi-omics. Ann. Neurol. 89, 546\u2013559 (2021).","journal-title":"Ann. Neurol."},{"key":"56829_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41576-021-00434-9","volume":"23","author":"S Whalen","year":"2022","unstructured":"Whalen, S., Schreiber, J., Noble, W. S. & Pollard, K. S. Navigating the pitfalls of applying machine learning in genomics. Nat. Rev. Genet. 23, 169\u2013181 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"56829_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2016.88","volume":"1","author":"S Vieira-Silva","year":"2016","unstructured":"Vieira-Silva, S. et al. Species\u2013function relationships shape ecological properties of the human gut microbiome. Nat. Microbiol. 1, 1\u20138 (2016).","journal-title":"Nat. Microbiol."},{"key":"56829_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","volume":"4","author":"M Valles-Colomer","year":"2019","unstructured":"Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623\u2013632 (2019).","journal-title":"Nat. Microbiol."},{"key":"56829_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-019-0104-6","volume":"6","author":"ZD Wallen","year":"2020","unstructured":"Wallen, Z. D. et al. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. Npj Park. Dis. 6, 1\u201312 (2020).","journal-title":"Npj Park. Dis."},{"key":"56829_CR30","doi-asserted-by":"crossref","unstructured":"Zheng, J. et al. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int. J. Syst. Evol. Microbiol. 70, 2782\u20132858 (2020).","DOI":"10.1099\/ijsem.0.004107"},{"key":"56829_CR31","doi-asserted-by":"publisher","first-page":"105327","DOI":"10.1016\/j.neuint.2022.105327","volume":"156","author":"D Yadav","year":"2022","unstructured":"Yadav, D. & Kumar, P. Restoration and targeting of aberrant neurotransmitters in Parkinson\u2019s disease therapeutics. Neurochem. Int. 156, 105327 (2022).","journal-title":"Neurochem. Int."},{"key":"56829_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel, S. P. et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat. Commun. 10, 310 (2019).","journal-title":"Nat. Commun."},{"key":"56829_CR33","doi-asserted-by":"crossref","unstructured":"Green, E. R. & Mecsas, J. in Virulence Mechanisms of Bacterial Pathogens (eds. Kudva, I. T. et al.) 213\u2013239 (ASM Press, Washington, DC, USA, 2016).","DOI":"10.1128\/9781555819286.ch8"},{"key":"56829_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1189\/jlb.4MR0716-330R","volume":"101","author":"D Ratner","year":"2017","unstructured":"Ratner, D., Orning, M. P. A. & Lien, E. Bacterial secretion systems and regulation of inflammasome activation. J. Leukoc. Biol. 101, 165\u2013181 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"56829_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","volume":"8","author":"REW Hancock","year":"2000","unstructured":"Hancock, R. E. W. & Diamond, G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8, 402\u2013410 (2000).","journal-title":"Trends Microbiol."},{"key":"56829_CR36","doi-asserted-by":"publisher","first-page":"e01462","DOI":"10.1128\/mBio.01462-18","volume":"9","author":"NTK Nhu","year":"2018","unstructured":"Nhu, N. T. K. et al. Discovery of new genes involved in Curli production by a uropathogenic Escherichia coli strain from the highly virulent O45:K1:H7 lineage. mBio 9, e01462\u201318 (2018).","journal-title":"mBio"},{"key":"56829_CR37","doi-asserted-by":"publisher","first-page":"e53111","DOI":"10.7554\/eLife.53111","volume":"9","author":"TR Sampson","year":"2020","unstructured":"Sampson, T. R. et al. A gut bacterial amyloid promotes \u03b1-synuclein aggregation and motor impairment in mice. ELife 9, e53111 (2020).","journal-title":"ELife"},{"key":"56829_CR38","doi-asserted-by":"publisher","first-page":"e1006654","DOI":"10.1371\/journal.ppat.1006654","volume":"13","author":"RP Friedland","year":"2017","unstructured":"Friedland, R. P. & Chapman, M. R. The role of microbial amyloid in neurodegeneration. PLOS Pathog. 13, e1006654 (2017).","journal-title":"PLOS Pathog."},{"key":"56829_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuro.2012.01.010","volume":"33","author":"WM Caudle","year":"2012","unstructured":"Caudle, W. M., Guillot, T. S., Lazo, C. R. & Miller, G. W. Industrial toxicants and Parkinson\u2019s disease. NeuroToxicology 33, 178\u2013188 (2012).","journal-title":"NeuroToxicology"},{"key":"56829_CR40","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamaneurol.2023.1168","volume":"80","author":"SM Goldman","year":"2023","unstructured":"Goldman, S. M. et al. Risk of Parkinson disease among service members at Marine Corps Base Camp Lejeune. JAMA Neurol. 80, 673\u2013681 (2023).","journal-title":"JAMA Neurol."},{"key":"56829_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tox.2006.12.007","volume":"232","author":"NM Filipov","year":"2007","unstructured":"Filipov, N. M., Stewart, M. A., Carr, R. L. & Sistrunk, S. C. Dopaminergic toxicity of the herbicide atrazine in rat striatal slices. Toxicology 232, 68\u201378 (2007).","journal-title":"Toxicology"},{"key":"56829_CR42","doi-asserted-by":"publisher","first-page":"116176","DOI":"10.1016\/j.taap.2022.116176","volume":"451","author":"NM Ilieva","year":"2022","unstructured":"Ilieva, N. M., Wallen, Z. D. & De Miranda, B. R. Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: Relevance to idiopathic Parkinson\u2019s disease. Toxicol. Appl. Pharmacol. 451, 116176 (2022).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"56829_CR43","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primer 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"56829_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38248-4","volume":"14","author":"B Huang","year":"2023","unstructured":"Huang, B. et al. Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives. Nat. Commun. 14, 2501 (2023).","journal-title":"Nat. Commun."},{"key":"56829_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41531-022-00395-8","volume":"8","author":"JM Boertien","year":"2022","unstructured":"Boertien, J. M. et al. Fecal microbiome alterations in treatment-naive de novo Parkinson\u2019s disease. Npj Park. Dis. 8, 129 (2022).","journal-title":"Npj Park. Dis."},{"key":"56829_CR46","doi-asserted-by":"publisher","first-page":"728479","DOI":"10.3389\/fmicb.2021.728479","volume":"12","author":"L Mao","year":"2021","unstructured":"Mao, L. et al. Cross-sectional study on the gut microbiome of Parkinson\u2019s disease patients in central China. Front. Microbiol. 12, 728479 (2021).","journal-title":"Front. Microbiol."},{"key":"56829_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger, M. M. et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat. Disord. 32, 66\u201372 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"56829_CR48","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/codi.13314","volume":"18","author":"Y Shi","year":"2016","unstructured":"Shi, Y. et al. Function and clinical implications of short-chain fatty acids in patients with mixed refractory constipation. Colorectal Dis. 18, 803\u2013810 (2016).","journal-title":"Colorectal Dis."},{"key":"56829_CR49","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","volume":"50","author":"A Schwiertz","year":"2018","unstructured":"Schwiertz, A. et al. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 50, 104\u2013107 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"56829_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.copbio.2017.08.004","volume":"49","author":"DD Heeney","year":"2018","unstructured":"Heeney, D. D., Gareau, M. G. & Marco, M. L. Intestinal Lactobacillus in health and disease, a driver or just along for the ride? Curr. Opin. Biotechnol. 49, 140\u2013147 (2018).","journal-title":"Curr. Opin. Biotechnol."},{"key":"56829_CR51","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1128\/JCM.01500-13","volume":"52","author":"W Wang","year":"2014","unstructured":"Wang, W. et al. Increased proportions of bifidobacterium and the Lactobacillus group and loss of Butyrate-producing bacteria in inflammatory Bowel Disease. J. Clin. Microbiol. 52, 398\u2013406 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"56829_CR52","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1128\/IAI.73.5.2573-2585.2005","volume":"73","author":"J Garmendia","year":"2005","unstructured":"Garmendia, J., Frankel, G. & Crepin, V. F. Enteropathogenic and enterohemorrhagic Escherichia coli infections: Translocation, translocation, translocation. Infect. Immun. 73, 2573\u20132585 (2005).","journal-title":"Infect. Immun."},{"key":"56829_CR53","doi-asserted-by":"publisher","first-page":"113750","DOI":"10.1016\/j.celrep.2024.113750","volume":"43","author":"X Xu","year":"2024","unstructured":"Xu, X. & Foley, E. Vibrio cholerae arrests intestinal epithelial proliferation through T6SS-dependent activation of the bone morphogenetic protein pathway. Cell Rep. 43, 113750 (2024).","journal-title":"Cell Rep."},{"key":"56829_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41575-022-00663-1","volume":"20","author":"S Zundler","year":"2023","unstructured":"Zundler, S. et al. Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation. Nat. Rev. Gastroenterol. Hepatol. 20, 50\u201364 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"56829_CR55","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1126\/science.abi6087","volume":"374","author":"G Agirman","year":"2021","unstructured":"Agirman, G., Yu, K. B. & Hsiao, E. Y. Signaling inflammation across the gut-brain axis. Science 374, 1087\u20131092 (2021).","journal-title":"Science"},{"key":"56829_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01243-w","volume":"10","author":"A Parker","year":"2022","unstructured":"Parker, A. et al. Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain. Microbiome 10, 68 (2022).","journal-title":"Microbiome"},{"key":"56829_CR57","doi-asserted-by":"publisher","first-page":"eaag2770","DOI":"10.1126\/science.aag2770","volume":"356","author":"N Koppel","year":"2017","unstructured":"Koppel, N., Maini Rekdal, V. & Balskus, E. P. Chemical transformation of xenobiotics by the human gut microbiota. Science 356, eaag2770 (2017).","journal-title":"Science"},{"key":"56829_CR58","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41579-022-00681-5","volume":"20","author":"AE Lindell","year":"2022","unstructured":"Lindell, A. E., Zimmermann-Kogadeeva, M. & Patil, K. R. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. Nat. Rev. Microbiol. 20, 431\u2013443 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"56829_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"F Hopfner","year":"2017","unstructured":"Hopfner, F. et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res. 1667, 41\u201345 (2017).","journal-title":"Brain Res."},{"key":"56829_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi, S. et al. Alterations of the human gut microbiome in multiple sclerosis. Nat. Commun. 7, 12015 (2016).","journal-title":"Nat. Commun."},{"key":"56829_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0603-4","volume":"6","author":"JD Forbes","year":"2018","unstructured":"Forbes, J. D. et al. A comparative study of the gut microbiota in immune-mediated inflammatory diseases\u2014does a common dysbiosis exist? Microbiome 6, 221 (2018).","journal-title":"Microbiome"},{"key":"56829_CR62","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1016\/j.jtauto.2019.100032","volume":"3","author":"SN Choile\u00e1in","year":"2020","unstructured":"Choile\u00e1in, S. N. et al. CXCR3\u2009+\u2009T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome. J. Transl. Autoimmun. 3, 100032 (2020).","journal-title":"J. Transl. Autoimmun."},{"key":"56829_CR63","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/ana.26084","volume":"89","author":"LM Cox","year":"2021","unstructured":"Cox, L. M. et al. Gut microbiome in progressive multiple sclerosis. Ann. Neurol. 89, 1195\u20131211 (2021).","journal-title":"Ann. Neurol."},{"key":"56829_CR64","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute, E. et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc. Natl. Acad. Sci. USA 114, 10713\u201310718 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56829_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt, N. M. et al. Gut microbiome alterations in Alzheimer\u2019s disease. Sci. Rep. 7, 13537 (2017).","journal-title":"Sci. Rep."},{"key":"56829_CR66","doi-asserted-by":"publisher","first-page":"e00004","DOI":"10.1128\/msystems.00004-22","volume":"7","author":"S Y\u0131ld\u0131r\u0131m","year":"2022","unstructured":"Y\u0131ld\u0131r\u0131m, S. et al. Stratification of the gut microbiota composition landscape across the Alzheimer\u2019s disease continuum in a Turkish cohort. mSystems 7, e00004\u2013e00022 (2022).","journal-title":"mSystems"},{"key":"56829_CR67","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"Z-Q Zhuang","year":"2018","unstructured":"Zhuang, Z.-Q. et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J. Alzheimers Dis. 63, 1337\u20131346 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"56829_CR68","doi-asserted-by":"publisher","first-page":"634069","DOI":"10.3389\/fcell.2020.634069","volume":"8","author":"Z Ling","year":"2021","unstructured":"Ling, Z. et al. Structural and functional dysbiosis of fecal microbiota in Chinese patients with Alzheimer\u2019s disease. Front. Cell Dev. Biol. 8, 634069 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"56829_CR69","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jalz.2019.07.002","volume":"15","author":"B Li","year":"2019","unstructured":"Li, B. et al. Mild cognitive impairment has similar alterations as Alzheimer\u2019s disease in gut microbiota. Alzheimers Dement 15, 1357\u20131366 (2019).","journal-title":"Alzheimers Dement"},{"key":"56829_CR70","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"56829_CR71","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10 (2011).","journal-title":"EMBnet. J."},{"key":"56829_CR72","doi-asserted-by":"publisher","first-page":"D785","DOI":"10.1093\/nar\/gkab776","volume":"50","author":"DH Parks","year":"2022","unstructured":"Parks, D. H. et al. GTDB: an ongoing census of bacterial and archaeal diversity through a phylogenetically consistent, rank normalized and complete genome-based taxonomy. Nucleic Acids Res. 50, D785\u2013D794 (2022).","journal-title":"Nucleic Acids Res."},{"key":"56829_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01410-z","volume":"10","author":"H-J Ruscheweyh","year":"2022","unstructured":"Ruscheweyh, H.-J. et al. Cultivation-independent genomes greatly expand taxonomic-profiling capabilities of mOTUs across various environments. Microbiome 10, 212 (2022).","journal-title":"Microbiome"},{"key":"56829_CR74","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41586-021-04233-4","volume":"601","author":"LP Coelho","year":"2022","unstructured":"Coelho, L. P. et al. Towards the biogeography of prokaryotic genes. Nature 601, 252\u2013256 (2022).","journal-title":"Nature"},{"key":"56829_CR75","unstructured":"Bushnell, B. BBMap: A Fast, Accurate, Splice-Aware Aligner. https:\/\/www.osti.gov\/biblio\/1241166 (2014)."},{"key":"56829_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).","journal-title":"Genome Biol."},{"key":"56829_CR77","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2012","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2012).","journal-title":"Nucleic Acids Res."},{"key":"56829_CR78","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/bioinformatics\/btac137","volume":"38","author":"Y Jung","year":"2022","unstructured":"Jung, Y. & Han, D. BWA-MEME: BWA-MEM emulated with a machine learning approach. Bioinformatics 38, 2404\u20132413 (2022).","journal-title":"Bioinformatics"},{"key":"56829_CR79","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"56829_CR80","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/bioinformatics\/btz859","volume":"36","author":"T Aramaki","year":"2020","unstructured":"Aramaki, T. et al. KofamKOALA: KEGG Ortholog assignment based on profile HMM and adaptive score threshold. Bioinformatics 36, 2251\u20132252 (2020).","journal-title":"Bioinformatics"},{"key":"56829_CR81","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ismej.2015.188","volume":"10","author":"Y Darzi","year":"2016","unstructured":"Darzi, Y., Falony, G., Vieira-Silva, S. & Raes, J. Towards biome-specific analysis of meta-omics data. ISME J. 10, 1025\u20131028 (2016).","journal-title":"ISME J."},{"key":"56829_CR82","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/pro.4172","volume":"31","author":"M Kanehisa","year":"2022","unstructured":"Kanehisa, M., Sato, Y. & Kawashima, M. KEGG mapping tools for uncovering hidden features in biological data. Protein Sci. 31, 47\u201353 (2022).","journal-title":"Protein Sci."},{"key":"56829_CR83","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403\u2013410 (1990).","journal-title":"J. Mol. Biol."},{"key":"56829_CR84","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, Vienna, Austria, 2019)."},{"key":"56829_CR85","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).","journal-title":"PLoS ONE"},{"key":"56829_CR86","unstructured":"Oksanen, J. et al. Vegan: Community Ecology Package. (2019)."},{"key":"56829_CR87","doi-asserted-by":"crossref","unstructured":"Johns, H. Genodds: Generalized Odds Ratios. (2019).","DOI":"10.32614\/CRAN.package.genodds"},{"key":"56829_CR88","doi-asserted-by":"crossref","unstructured":"Balduzzi, S., R\u00fccker, G. & Schwarzer, G. How to perform a meta-analysis with R: a practical tutorial. Evid. Based Ment. Health 22, 153\u2013160 (2019).","DOI":"10.1136\/ebmental-2019-300117"},{"key":"56829_CR89","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"56829_CR90","unstructured":"Miller, T. L. Regression Subset Selection. (2020)."},{"key":"56829_CR91","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.29300","volume":"38","author":"J Boktor","year":"2022","unstructured":"Boktor, J. Integrated multi-cohort analysis of the Parkinson\u2019s disease gut metagenome. Mov. Disord. 38, 399\u2013409 (2022).","journal-title":"Mov. Disord."},{"key":"56829_CR92","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov, V. A. et al. Analysis of Gut Microbiota in Patients with Parkinson\u2019s Disease. Bull. Exp. Biol. Med. 162, 734\u2013737 (2017).","journal-title":"Bull. Exp. Biol. Med."},{"key":"56829_CR93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian, Y. et al. Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain. Behav. Immun. 70, 194\u2013202 (2018).","journal-title":"Brain. Behav. Immun."},{"key":"56829_CR94","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian, A. et al. Colonic bacterial composition in Parkinson\u2019s disease: COLONIC MICROBIOTA IN PARKINSON\u2019S DISEASE. Mov. Disord. 30, 1351\u20131360 (2015).","journal-title":"Mov. Disord."},{"key":"56829_CR95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-019-0100-x","volume":"5","author":"S Weis","year":"2019","unstructured":"Weis, S. et al. Effect of Parkinson\u2019s disease and related medications on the composition of the fecal bacterial microbiota. Npj Park. Dis. 5, 28 (2019).","journal-title":"Npj Park. Dis."},{"key":"56829_CR96","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea, M. S. et al. Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov. Disord. 35, 1208\u20131217 (2020).","journal-title":"Mov. Disord."},{"key":"56829_CR97","unstructured":"Pinheiro, J., Bates, D., & R. Core Team. Nlme: Linear and Nonlinear Mixed Effects Models. (2023)."},{"key":"56829_CR98","doi-asserted-by":"crossref","unstructured":"Pinheiro, J. C. & Bates, D. M. Mixed-Effects Models in S and S-PLUS. (Springer, New York, 2000).","DOI":"10.1007\/978-1-4419-0318-1"},{"key":"56829_CR99","unstructured":"Helleputte, T., Gramme, P. & Paul, J. Linear Predictive Models Based on the LIBLINEAR C\/C\u2009+\u2009+ Library. (2022)."},{"key":"56829_CR100","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1198\/000313006X118430","volume":"60","author":"T Hothorn","year":"2006","unstructured":"Hothorn, T., Hornik, K., van de Wiel, M. A. & Zeileis, A. A lego system for conditional inference. Am. Stat. 60, 257\u2013263 (2006).","journal-title":"Am. Stat."},{"key":"56829_CR101","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.21105\/joss.03139","volume":"6","author":"D L\u00fcdecke","year":"2021","unstructured":"L\u00fcdecke, D., Ben-Shachar, M. S., Patil, I., Waggoner, P. & Makowski, D. performance: An R package for assessment, comparison and testing of statistical models. J. Open Source Softw. 6, 3139 (2021).","journal-title":"J. Open Source Softw."},{"key":"56829_CR102","unstructured":"Lenth, R. V. Emmeans: Estimated Marginal Means, Aka Least-Squares Means. (2023)."},{"key":"56829_CR103","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1093\/bioinformatics\/btx206","volume":"33","author":"P Saary","year":"2017","unstructured":"Saary, P., Forslund, K., Bork, P. & Hildebrand, F. RTK: efficient rarefaction analysis of large datasets. Bioinformatics 33, 2594\u20132595 (2017).","journal-title":"Bioinformatics"},{"key":"56829_CR104","unstructured":"Kassambara A. _rstatix: Pipe-Friendly Framework for Basic Statistical Tests_. R package version 0.7.2, https:\/\/CRAN.R-project.org\/package=rstatix (2023)."},{"key":"56829_CR105","doi-asserted-by":"publisher","unstructured":"Siyuan Ma. MMUPHin: Meta-analysis methods with uniform pipeline for heterogeneity in microbiome studies. Zenodo https:\/\/doi.org\/10.5281\/ZENODO.7008567 (2022).","DOI":"10.5281\/ZENODO.7008567"},{"key":"56829_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-015-0870-z","volume":"17","author":"R Hornung","year":"2016","unstructured":"Hornung, R., Boulesteix, A.-L. & Causeur, D. Combining location-and-scale batch effect adjustment with data cleaning by latent factor adjustment. BMC Bioinformatics 17, 27 (2016).","journal-title":"BMC Bioinformatics"},{"key":"56829_CR107","doi-asserted-by":"publisher","unstructured":"Kenna, J. E. et al. Changes in the gut microbiome and predicted functional metabolic effects in an Australian Parkinson\u2019s disease cohort. Front. Neurosci. 15, https:\/\/doi.org\/10.3389\/fnins.2021.756951 (2021).","DOI":"10.3389\/fnins.2021.756951"},{"key":"56829_CR108","doi-asserted-by":"publisher","unstructured":"Kenna, J. (2021). Raw sequencing data. figshare. Dataset. https:\/\/doi.org\/10.6084\/m9.figshare.14345513.v1 (2020).","DOI":"10.6084\/m9.figshare.14345513.v1"},{"key":"56829_CR109","doi-asserted-by":"publisher","unstructured":"Romano, S. StfnRomano\/PD_ML_meta: v1.0.0 (v1.0.0). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.14698367 (2025).","DOI":"10.5281\/zenodo.14698367"},{"key":"56829_CR110","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart, A. et al. The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder: Nose and Gut Microbiome in PD and iRBD. Mov. Disord. 33, 88\u201398 (2018).","journal-title":"Mov. Disord."},{"key":"56829_CR111","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","volume":"65","author":"D Pietrucci","year":"2019","unstructured":"Pietrucci, D. et al. Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients. Parkinsonism Relat. Disord. 65, 124\u2013130 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"56829_CR112","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho, V. T. E. et al. Gut microbiota in Parkinson\u2019s disease: Temporal stability and relations to disease progression. EBioMedicine 44, 691\u2013707 (2019).","journal-title":"EBioMedicine"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56829-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56829-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56829-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T07:04:22Z","timestamp":1746601462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56829-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56829"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56829-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.05.569565","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"1 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4227"}}